Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRui‐Hua Xu, Lin Shen, Jianming Xu et al.|BMC Cancer|2017Cited by 15
A phase II study of Chinese patients (pts) treated with <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC).Lin Shen, Rui‐Hua Xu, Xianjun Yu et al.|Journal of Clinical Oncology|2016Cited by 2
223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II studyXianjun Yu, Rui Xu, Lin Shen et al.|Annals of Oncology|2015Cited by 0